Previous 10 | Next 10 |
Quick Take Varian ( VAR ) announced it has acquired CyberHeart for an undisclosed amount. CyberHeart has intellectual property that covers cardiac radioablation - the use of radiation to scar or destroy tissue in the heart that is facilitating faulty electrical signals, causing an abnorm...
AngioDynamics ( ANGO -5.6% ) slips on average volume in early trade on the heels of revised guidance accounting for the divestment of its NAMIC unit to Medline Industries announced yesterday. More news on: AngioDynamics, Inc., Healthcare stocks news, Stocks on the move, Read more...
AngioDynamics (NASDAQ: ANGO ) has agreed to sel l its NAMIC fluid management line to Medline Industries for $167.5M. More news on: AngioDynamics, Inc., Healthcare stocks news, Merger & acquisition news, Read more ...
AngioDynamics to host conference call today at 5:00 p.m. ET AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for oncology, vascular access, and peripheral vascular disease, today announced that it has entered into a definitive ...
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that the Company received central Institutional Review Board (IRB) approval to conduct its NanoKnife ® ...
The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more ...
AngioDynamics, Inc. (ANGO) Q3 2019 Results Earnings Conference Call April 02, 2019, 08:00 AM ET Company Participants Jim Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice Preside...
Stocks fell on Tuesday as investors digested a strong rally from the previous session, while a decline in Walgreens Boots Alliance shares also dampened sentiment. The Dow Jones Industrials slumped 78.46 points to 26,179.96, as Walgreens lagged. The S&P 500 handed back 1.13 points...
The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2019 Q3 earnings Read more ...
AngioDynamics ( ANGO ) Q3 results : Revenues: $86.3M (+2.9%). More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that its management is schedule...
Equity Bancshares Inc. Class A (EQBK) is expected to report $0.92 for Q2 2024 Bank of America Corporation (BAC) is expected to report $0.79 for Q2 2024 Aehr Test Systems (AEHR) is expected to report $0.09 for Q4 2024 America Movil S.A.B. de C.V.n Depositary Shares (each representing t...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourt...